Rhodopsin-associated retinal dystrophy: Disease mechanisms and therapeutic strategies

Fangyuan Zhen1,2, Tongdan Zou2, Ting Wang2

  • 1Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou, China.

Summary

Mutations in the rhodopsin gene (RHO) cause autosomal dominant retinitis pigmentosa (ADRP) through complex mechanisms. Emerging therapies like gene therapy show promise for treating vision loss.